Featured
Expert Content
Managing your pharmaceutical supply chain is a lot like following a good cake recipe. Both require thorough preparation, a comprehensive plan of action, and the best ingredients that come together to make something special - your drug product.
Articles
Contract dose manufacturers, including small-molecule and biologic outsourcing partners have had to respond rapidly in order to continue to meet customers’ rapidly shifting needs.
Drug sponsors know very well how essential it is to establish the TPP (Target Product Profile) of their prospective drug product as early as possible.
Over the past two decades, pharma’s acute focus on the patient has driven great innovation and investment in ways to deliver active pharmaceutical ingredients (APIs) in finished drug products, we discuss how FDCs have been gaining favor.
In an industry that is ever-evolving, trends and opportunities unfold at every turn. Our Global Business Development Lead Tom Wilson recently spoke with CPhI Online to share his insights on recent supply chain challenges and discuss the opportunities in the CDMO space.
What are the key drug dosage form trends happening in this space, and how can we expect them to change the future of patient-centric treatments? Our Director of Operations Dierdre Whelan discusses them in this piece.
News & Updates
On May 24th 2022, an opening ceremony was held for the opening of Pfizer’s newest production facility in Freiburg, Germany, which has been built with Bristol-Myers Squibb (BMS).
Although the oral solid dose therapeutics market dwarfs the number of sterile injectables consumed around the world, parenteral drug administration is still growing. In this article Martin Gonzales explores the key trends and developments in injectable drug formulation and delivery.
For over 40 years, we've been listening, solving, and guiding our partners' drug projects to success. But what makes us an altogether different kind of CDMO to work with? Find out here.
The first annual CDMO of the Year Award by the Medicine Maker has wrapped up for 2022 and we’re pleased to announce that Pfizer CentreOne has been crowned the winner!
Prefilled syringes (PFS) have become an increasingly attractive choice for medical professionals, especially in recent years in this article we’ll be discussing the differences between glass vials and PFS that manufacturers must account for in their switch to PFS devices.
The development of parenteral drugs has increased significantly, with the market set to reach $1.2 billion USD by 20281.
